You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Apparatus and Method for Convection Enhanced Therapeutic Delivery

    SBC: FHC, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Malignancies of the brain are among the most devastating diseases known. Glioblastoma multiform (GBM) in particular are known for their rapid, uncontrolled, and aggressive growth. Very little progress has been made in the treatment of GBM over the past 25 years. A more recent promising therapeutic approach is convection enhanced delivery (CED) in which chemothe ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  2. Lung nodule detection using 3D visual palpation via standard thoracoscopes

    SBC: LUCIDUX            Topic: NIBIB

    DESCRIPTION (provided by applicant): Surgeons perform tens of thousands of operations each year to resect suspicious lung nodules. Historically this necessitated an open surgical approach (thoracotomy) through a large chest wall incision. Over the last 10-15 years, minimally invasive surgical (MIS) approaches have become increasingly common in abdominal and thoracic surgery, with significant benef ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  3. Development of a Topical Choroid Plexus Factor Product to Accelerate Wound Healin

    SBC: CYTOSOLV INC.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Chronic superficial wounds are difficult to treat and often never completely heal. Diabetic foot complications account for the majority of lower limb amputations in the world, and 25% of all diabetic hospital admissionsin the US. The standard of care for these wounds has been unchanged for decades, and remains reduced weight bearing, debridement, antibiotics, a ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  4. An Innovative New Stroke Rehabilitation Tool: The Shoulder SOS

    SBC: MEDEON, LLC            Topic: NICHD

    DESCRIPTION (provided by applicant): Where arm functioning has been compromised due to a stroke, brain injury, or other neurological injury and rehabilitative progress is to be obtained in the upper extremity, it is crucial to limit over-stretching of theshoulder joint (attributed to lost muscle tone) and to control pain. Medeon, LLC is actively working with rehabilitation experts to develop the ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  5. A Biomimetic Prehensile Digit for Upper-Limb Prostheses

    SBC: Invisible Hand Enterprises, LLC            Topic: NICHD

    DESCRIPTION (provided by applicant): Among amputation types involving the upper limbs, partial hand is the most prevalent by far and among the most challenging for prosthetists to address well. Sound side overreliance for these amputees gives rise to a high prevalence of contralateral overuse syndrome (COS), a progressive, painful, and debilitating condition. Research shows that prostheses reduce ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  6. Development of algorithm for identification of functional self-delivering RNAi co

    SBC: ADVANCED RNA TECHNOLOGIES, LLC            Topic: NHGRI

    DESCRIPTION (provided by applicant): Introduction of small interfering RNAs (siRNAs) into cells with transfection reagents results in efficient gene silencing. Unfortunately, while siRNA-based functional genomics is widely used in vitro, the ability to apply this technology to primary cells and in vivo target validation has been impeded limited availability of efficient and non-toxic delivery syst ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  7. A Compact, Portable Oxygen Generator

    SBC: TDA RESEARCH, INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): In this Phase I SBIR project, TDA Research, Inc. will develop a compact, lightweight portable oxygen concentrator (POC) for medical operations and carry out a breadboard demonstration to produce continuous flow of enriched oxygen (O2) from ambient air. The new POC will weigh less than 10 lbs including the rechargeable batteries that will provide a minimum of 10 ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  8. Noninvasive Total Hemoglobin Monitor

    SBC: Kestrel Labs Inc            Topic: NHLBI

    DESCRIPTION (provided by applicant): It is a rare event when new and useful medical parameters can be added to the suite of monitoring and diagnostic tests available in a clinical setting. Of particular importance is the ability to measure crucial physiological parameters or analytes in a continuous and noninvasive manner-evidenced by the importance of noninvasive vital signs monitoring-because it ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  9. Micro-patterned Surfaces for Reducing the Risk of Ventilator-Associated Pneumonia

    SBC: Sharklet Technologies Inc.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Ventilator-associated pneumonia (VAP) is the most costly and second most common hospital-acquired infection (HAI), accounting for over 86% of hospital-acquired pneumonia (HAP). Some 300,000 HAP patients are treated annually in the U.S., at an estimated annual hospital cost of more than 1.5 billion. The current paradigm for preventing VAP has been to implement ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  10. Treatment of stroke using a novel PDZ binding peptidomimetic drug.

    SBC: Ardane Therapeutics Inc.            Topic: NINDS

    DESCRIPTION (provided by applicant): Abstract Stroke is the third leading pathological cause of death, behind heart and cancer (NCHS mortality data.). We are developing a new drug, CN 2097, that has demonstrated therapeutic potential for stroke. CN 2097 obstructs the propagation of the cell death signal whilst not interfering with normal neuronal transmission, thus reducing the incidence of si ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government